 |
인쇄하기
취소
|
Pfizer and Pharmacia agreed in US$60 billion stock deal
Another big deal was recently made available, one year after the M&A deal between Glaxo Wellcome and SmithKline Beecham.
The Wall Street Journal reported on July 15 that Pfizer Inc. has agreed to buy Pharmacia Corp. for US$60 billion.
The deal notes that all rights of Pharmacia's blockbuster anti-arthritic agent Celebrex will be assigned to Pfizer.
Market analysts say the Pfizer-Phar...
The Wall Street Journal reported on July 15 that Pfizer Inc. has agreed to buy Pharmacia Corp. for US$60 billion.
The deal notes that all rights of Pharmacia's blockbuster anti-arthritic agent Celebrex will be assigned to Pfizer.
Market analysts say the Pfizer-Phar...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.